MedGenome Labs Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
1,024
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$47.5M
- Investors
-
9
MedGenome Labs General Information
Description
Developer of sequencing genomics-based diagnostics and research platform intended for patients, pharmaceutical companies, and research institutions around the world. The company's platform applies genomics technologies, bioinformatics, computing and big data analytics to the genetically diverse and large population to understand the genetic basis of cancer, metabolic disorders, eye disorders and other rare diseases, and offers high-end genetic diagnostic tests across various disease categories; immuno-oncology, infectious diseases, reproductive health and rare diseases, enabling the healthcare industry to develop deep insights into diseases at the genetic and molecular level.
Contact Information
Website
diagnostics.medgenome.comCorporate Office
- Ground Floor, Sy Number 94/1C and 94/2, E City Tower 1
- 2nd Cross Road, Electronic City Phase I
- Bangalore, Karnataka 560100
- India
Corporate Office
- Ground Floor, Sy Number 94/1C and 94/2, E City Tower 1
- 2nd Cross Road, Electronic City Phase I
- Bangalore, Karnataka 560100
- India
MedGenome Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series E) | 21-Jul-2025 | $47.5M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series D) | 30-Aug-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C3) | 15-Jul-2021 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 5. Later Stage VC (Series C2) | 01-Jan-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C1) | 28-Aug-2017 | Completed | Generating Revenue | |||
| 3. Debt - General | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series B) | 05-Jul-2015 | $20M | $24M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 04-Jun-2014 | $4M | $4M | Completed | Startup |
MedGenome Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D2 | ||||||||
| Series D1 | ||||||||
| Series C3 | ||||||||
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | 4,921,022 | $0.000100 | $1.93 | $1.93 | 1x | $1.93 | 8.52% | |
| Series A | 6,952,894 | $0.000100 | $0.55 | $0.55 | 1x | $0.55 | 12.03% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MedGenome Labs Comparisons
Industry
Financing
Details
MedGenome Labs Competitors (9)
One of MedGenome Labs’s 9 competitors is Strand (Biotechnology), a Formerly VC-backed company based in Bangalore, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Strand (Biotechnology) | Formerly VC-backed | Bangalore, India | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Positive Biosciences | Corporation | Mumbai, India | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| Neuberg Diagnostics | Private Equity-Backed | Chennai, India |
MedGenome Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MedGenome Labs Patents
MedGenome Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019036043-A2 | A method to generate a cocktail of personalized cancer vaccines from tumor-derived genetic alterations for the treatment of cancer | Inactive | 16-Aug-2017 | ||
| WO-2019036043-A3 | A method to generate a cocktail of personalized cancer vaccines from tumor-derived genetic alterations for the treatment of cancer | Inactive | 16-Aug-2017 | ||
| US-10350280-B2 | Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore | Active | 31-Aug-2016 | ||
| US-20180085447-A1 | Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore | Active | 31-Aug-2016 | ||
| US-20190237158-A1 | Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore | Inactive | 31-Aug-2016 | G16B20/30 |
MedGenome Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MedGenome Labs Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Maj Invest | PE/Buyout | Minority | ||
| Avendus Capital | Asset Manager | Minority | ||
| HDFC Bank | Corporation | Minority | ||
| Madison India Capital | Growth/Expansion | Minority | ||
| Novo Holdings | Venture Capital | Minority |
MedGenome Labs Investments & Acquisitions (8)
MedGenome Labs’s most recent deal was a Merger/Acquisition with Siddhi Diagnostics & Research Centre for . The deal was made on 14-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Siddhi Diagnostics & Research Centre | 14-May-2026 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Medcare Management Services | 02-Mar-2026 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| GreenCross Genetics Lab | 04-Nov-2025 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| PacBio (Revio sequencing system) | 18-Jul-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Gen X Diagnostics | 10-Jul-2024 | Merger/Acquisition | Laboratory Services (Healthcare) |
MedGenome Labs Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Trident Diagnostics | Bengaluru, India | 2015 | |
| Medcare Management Services | Mumbai, India | 2006 | |
| Gen X Diagnostics | New Delhi, India | 2003 | |
| Prognosis Laboratories | New Delhi, India | 2002 | |
| Siddhi Diagnostics & Research Centre | Palghar, India | 1995 |
MedGenome Labs FAQs
-
When was MedGenome Labs founded?
MedGenome Labs was founded in 2013.
-
Where is MedGenome Labs headquartered?
MedGenome Labs is headquartered in Bangalore, India.
-
What is the size of MedGenome Labs?
MedGenome Labs has 1,024 total employees.
-
What industry is MedGenome Labs in?
MedGenome Labs’s primary industry is Laboratory Services (Healthcare).
-
Is MedGenome Labs a private or public company?
MedGenome Labs is a Private company.
-
What is the current valuation of MedGenome Labs?
The current valuation of MedGenome Labs is .
-
What is MedGenome Labs’s current revenue?
The current revenue for MedGenome Labs is .
-
How much funding has MedGenome Labs raised over time?
MedGenome Labs has raised $223M.
-
Who are MedGenome Labs’s investors?
Maj Invest, Avendus Capital, HDFC Bank, Madison India Capital, and Novo Holdings are 5 of 9 investors who have invested in MedGenome Labs.
-
Who are MedGenome Labs’s competitors?
Strand (Biotechnology), Foundation Medicine, Positive Biosciences, Ambry Genetics, and Neuberg Diagnostics are some of the 9 competitors of MedGenome Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
